[Treatment of liver cirrhosis - actually possibility of ambulant internist] [0.03%]
肝硬化的治疗-内科医生的实际可能性？
Jiří Ehrmann,Květa Aiglová,Michal Konečný et al.
Jiří Ehrmann et al.
There are 40 000-60 000 patients with cirrhosis in the Czech Republic. 2 000 die of this disease yearly. This group of patients needs a complex treatment and it is mostly an internist cooperating with other specialists. The most important f...
Jan Brož,Pavlína Piťhová,Denisa Janíčková Žďárská
Jan Brož
Impaired hypoglycemia awareness is defined at the onset of neuroglycopenia without the appearance of autonomic warning symptoms. Impaired hypoglycemia awareness is disorder which affects aprox. one third of patients with type 1 diabetes mel...
[Changes in nutritional recommendations for a healthy population and their influence on a diabetic diet] [0.03%]
膳食推荐的变化及其对糖尿病饮食的影响
Michal Anděl,Ludmila Brunerová,Pavel Dlouhý et al.
Michal Anděl et al.
Recently, thousands of papers brought knowledge about effects of nutrients on cellular level, in experimental animals and in human experiments on one side, the results of epidemiological studies on the other side have suggested the nutrient...
Alena Adamíková
Alena Adamíková
Chronic long term hyperglycemia plays a key role in the pathogenesis of micro and macrovascular complications. The UKPDS study and its further analysis has proved that reduction of the value of glycated hemoglobin by 1 % leads to a 14 % red...
Review
Vnitrni lekarstvi. 2016 Fall;62(7-8):534-8. DOI: 2016
[Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients] [0.03%]
自身免疫性胰岛炎在2型糖尿病患者中的发生率：一项住院患者的随机临床试验
Emil Martinka,Mariana Rončáková,Michaela Mišániková et al.
Emil Martinka et al.
Background: It is not always easy to classify diabetes (DM) diagnosed in adults, with a significant group of patients initially classified and treated for type 2 diabetes mellitus (DM2T) presenting signs indicating the pr...
Randomized Controlled Trial
Vnitrni lekarstvi. 2016 Fall;62(7-8):521-33. DOI: 2016
[Estimating the prevalence of potential drug interactions in patients treated with 5 and more drugs in the Czech Republic and Slovac Repuplic] [0.03%]
估计捷克共和国和斯洛伐克共和国接受5种及以上药物治疗的患者中潜在药物相互作用的发生率
Richard Češka,Ivan Tkáč
Richard Češka
Polypragmasy is currently a growing phenomenon, leading to an increased risk of drug interactions. Empirical data to document this trend can only be obtained through a field survey, which, however, is missing in both Czechia and Slovakia. T...
Observational Study
Vnitrni lekarstvi. 2016 Fall;62(7-8):514-20. DOI: 2016
[Sinus histiocytosis with massive lymphadenopathy: FDG-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine] [0.03%]
[2-氯脱氧鸟苷治疗后的弗吉尼亚瘤巨细胞组织细胞增生症的FDG-PET/CT检查部分缓解的病例报告]
Zdeněk Adam,Jiří Mašlaň,Leoš Křen et al.
Zdeněk Adam et al.
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) is a very rare disease belonging to a group of histiocytoses (more precisely non-Langerhans cell histiocytoses). Rosai-Dorfman disease is characterised by the presence...
Tomáš Pelcl,Martin Prázný
Tomáš Pelcl
Treatment of diabetes mellitus with insulin is associated with a large number of subcutaneous injections. Incorrect insulin application technique can lead to complications both local (lipohypertrophy, scars) and systemic (high variability o...
[microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures] [0.03%]
[微小核糖核酸与内科：从病理生理学到新的诊疗程序]
Jan Novak,Miroslav Souček
Jan Novak
microRNAs (abbreviated miRNAs or miRs) represents one of the group of so called small non-coding RNAs which participate in the negative post-transcriptional regulation of gene expression. According to the base complementarity they target mo...
[Komentář ke článku HOPE-3: Statins Lower CV Events in Intermediate-CHD-Risk Patients] [0.03%]
[HOPE-3研究述评：他汀可使中危冠心病患者减少心血管事件]
Jiří Widimský
Jiří Widimský
The HOPE-3 study focused on identifying the significance of the polypill and mini-polypill in broad clinical practice, including individuals of different gender without cardiovascular diseases with an intermediate risk of cardiovascular dis...